Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL
Clinical trial NCT02564744 · COMPLETED
Trial details
- NCT number
- NCT02564744
- Sponsor
- Debiopharm International SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-05
- Primary completion
- 2021-01-13
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.